ASX - Delayed Quote
AUD
Paradigm Biopharmaceuticals Limited (PAR.AX)
0.2450
0.0000
(0.00%)
At close: September 18 at 4:10:25 PM GMT+10
Loading chart for PAR.AX
- Previous Close
0.2450 - Open
0.2550 - Bid 0.2400 x --
- Ask 0.2550 x --
- Day's Range
0.2450 - 0.2650 - 52 Week Range
0.1350 - 0.4300 - Volume
3,137,503 - Avg. Volume
1,565,473 - Market Cap (intraday)
153.476M - Beta (5Y Monthly) 0.03
- PE Ratio (TTM)
-- - EPS (TTM)
-0.1500 - Earnings Date (est.) --
- Forward Dividend & Yield -- (0.00%)
- Ex-Dividend Date --
- 1y Target Est
1.08
Recent News
View MorePerformance Overview
Trailing total returns as of 10/30/2026, which may include dividends or other distributions. Benchmark is S&P/ASX 200 [XJO] (^AXJO) .
YTD Return
PAR.AX
27.94%
S&P/ASX 200 [XJO] (^AXJO)
2.22%
1-Year Return
PAR.AX
42.35%
S&P/ASX 200 [XJO] (^AXJO)
0.29%
3-Year Return
PAR.AX
59.04%
S&P/ASX 200 [XJO] (^AXJO)
31.37%
5-Year Return
PAR.AX
87.68%
S&P/ASX 200 [XJO] (^AXJO)
21.63%
Analyst Insights
View MoreStatistics
View MoreValuation Measures
-
Market Cap
-
Enterprise Value
-
Trailing P/E
-
Forward P/E
-
PEG Ratio (current)
-
Price/Sales (ttm)
-
Price/Book (mrq)
-
Enterprise Value/Revenue
-
Enterprise Value/EBITDA
Financial Highlights
Profitability and Income Statement
-
Profit Margin
0.00%
-
Return on Assets (ttm)
-138.75%
-
Return on Equity (ttm)
-456.96%
-
Revenue (ttm)
--
-
Net Income Avi to Common (ttm)
-56.33M
-
Diluted EPS (ttm)
-0.1500
Balance Sheet and Cash Flow
-
Total Cash (mrq)
15.44M
-
Total Debt/Equity (mrq)
216.37%
-
Levered Free Cash Flow (ttm)
-28.63M
